These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16754969)
1. Purification, crystallization and X-ray diffraction analysis of the C-terminal protease domain of Venezuelan equine encephalitis virus nsP2. Russo AT; Watowich SJ Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):514-7. PubMed ID: 16754969 [TBL] [Abstract][Full Text] [Related]
2. The crystal structure of the Venezuelan equine encephalitis alphavirus nsP2 protease. Russo AT; White MA; Watowich SJ Structure; 2006 Sep; 14(9):1449-58. PubMed ID: 16962975 [TBL] [Abstract][Full Text] [Related]
3. Proteolytic cleavage of host proteins by the Group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus. Morazzani EM; Compton JR; Leary DH; Berry AV; Hu X; Marugan JJ; Glass PJ; Legler PM Antiviral Res; 2019 Apr; 164():106-122. PubMed ID: 30742841 [TBL] [Abstract][Full Text] [Related]
4. Preparation and crystallization of a complex between human adenovirus serotype 2 proteinase and its 11-amino-acid cofactor pVIc. McGrath WJ; Ding J; Sweet RM; Mangel WF J Struct Biol; 1996; 117(1):77-9. PubMed ID: 8776891 [TBL] [Abstract][Full Text] [Related]
5. Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates. Bozóki B; Mótyán JA; Hoffka G; Waugh DS; Tőzsér J Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081394 [TBL] [Abstract][Full Text] [Related]
6. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. Rosas CT; Paessler S; Ni H; Osterrieder N Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789 [TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary X-ray diffraction analysis of bacteriophage varphi12 packaging factor P7. Kainov DE; Simonov V; Bamford DH; Tuma R; Gottlieb P; Wei H; Walsh MA; Belrhali H; Merckel MC Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2368-70. PubMed ID: 15583391 [TBL] [Abstract][Full Text] [Related]
8. Crystallization of foot-and-mouth disease virus 3C protease: surface mutagenesis and a novel crystal-optimization strategy. Birtley JR; Curry S Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):646-50. PubMed ID: 15858279 [TBL] [Abstract][Full Text] [Related]
9. Mutation of Asn-475 in the Venezuelan Equine Encephalitis Virus nsP2 Cysteine Protease Leads to a Self-Inhibited State. Compton JR; Mickey MJ; Hu X; Marugan JJ; Legler PM Biochemistry; 2017 Nov; 56(47):6221-6230. PubMed ID: 29064679 [TBL] [Abstract][Full Text] [Related]
10. [Expression and purification of porcine reproductive and respiratory syndrome virus Nsp2 protein and analysis of cleavage activity]. Qu H; Li Y; Hou Y; Yan J Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1502-9. PubMed ID: 20112680 [TBL] [Abstract][Full Text] [Related]
11. Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease. Hu X; Compton JR; Leary DH; Olson MA; Lee MS; Cheung J; Ye W; Ferrer M; Southall N; Jadhav A; Morazzani EM; Glass PJ; Marugan J; Legler PM Biochemistry; 2016 May; 55(21):3007-19. PubMed ID: 27030368 [TBL] [Abstract][Full Text] [Related]
12. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
13. Resolution improvement of X-ray diffraction data of crystals of a vesicular stomatitis virus nucleocapsid protein oligomer complexed with RNA. Green TJ; Luo M Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):498-504. PubMed ID: 16627942 [TBL] [Abstract][Full Text] [Related]
14. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186 [TBL] [Abstract][Full Text] [Related]
15. Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates. Saisawang C; Sillapee P; Sinsirimongkol K; Ubol S; Smith DR; Ketterman AJ Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182358 [TBL] [Abstract][Full Text] [Related]
16. A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease. Campos-Gomez J; Ahmad F; Rodriguez E; Saeed MF Virology; 2016 Sep; 496():77-89. PubMed ID: 27261892 [TBL] [Abstract][Full Text] [Related]
17. Self-inhibited State of Venezuelan Equine Encephalitis Virus (VEEV) nsP2 Cysteine Protease: A Crystallographic and Molecular Dynamics Analysis. Hoffka G; Lountos GT; Needle D; Wlodawer A; Waugh DS; Tőzsér J; Mótyán JA J Mol Biol; 2023 Mar; 435(6):168012. PubMed ID: 36792007 [TBL] [Abstract][Full Text] [Related]
18. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection. Turell MJ; Parker MD Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440 [TBL] [Abstract][Full Text] [Related]
19. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Lorenz IC; Marcotrigiano J; Dentzer TG; Rice CM Nature; 2006 Aug; 442(7104):831-5. PubMed ID: 16862121 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, overproduction, purification and biochemical characterization of the p39 nsp2 protease domains encoded by three alphaviruses. Zhang D; Tözsér J; Waugh DS Protein Expr Purif; 2009 Mar; 64(1):89-97. PubMed ID: 19013248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]